AGIO

AGIOS PHARMACEUTICALS, INC.

AGIO · CIK 1439222 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$54M
20182025
Net Income−$413M
20182025
Operating CF−$373M
20182025
Free Cash Flow−$377M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.1B$0.0B$0.0B$0.0B—$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B—$0.0B$0.0B$0.0B
Gross Profit————————
R&D Expense$0.3B$0.3B$0.3B$0.3B$0.3B$0.4B$0.4B$0.3B
SG&A Expense$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Operating Income$-0.5B$-0.4B$-0.4B$-0.4B$-0.4B$-0.1B$-0.1B$-0.1B
Net Income$-0.4B$0.7B$-0.4B$-0.2B$1.6B$-0.3B$-0.4B$-0.3B
EPS (Basic)$-7.12$11.86$-6.33$-4.23$-1.74———
EPS (Diluted)$-7.12$11.64$-6.33$-4.23$-1.74———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.3B$1.7B$0.9B$1.2B$1.4B$0.9B$0.9B$0.9B
Current Assets$0.9B$1.0B$0.8B$0.8B$1.1B$0.6B$0.6B$0.6B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B
Total Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.5B$0.3B$0.2B
Current Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$1.2B$1.5B$0.8B$1.1B$1.3B$0.4B$0.6B$0.7B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.4B$-0.4B$-0.3B$-0.3B$-0.4B$-0.3B$-0.4B$-0.3B
Investing Cash Flow$0.4B$0.4B$0.2B$0.2B$1.2B$0.1B$0.1B$-0.3B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$-0.8B$0.3B$0.3B$0.5B
← Companies